Kezar Life Sciences Inc. (KZR) Fundamentals

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.
SHARE INFORMATION
Market Cap$ 491,638,244
Shares Outstanding68,378,059
Float60,206,371
Percent Float88.05%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.04
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions316
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months14,352,916
Institutional Holdings Percent127.8%
Institutional Sold Previous 3 Months8,549,248
Insider Holdings Date2022-11-30
Insider Bought Previous 3 Months27,000
Insider Holdings Percent2.6
Insider Sold Previous 3 Months59,312
Insider Shares Owned1,756,473
TRADING INFO
52 Week High$ 18.55
52 Week Low$ 4.31
52 Week High Change$ -46.50
21 Day Moving Average$ 7.4271
21 Day Extended Moving Average$ 7.4668
50 Day Moving Average$ 7.6667
50 Day Extended Moving Average$ 7.7735
200 Day Moving Average$ 9.7047
200 Day Extended Moving Average$ 8.9723
10 Day Average Volume589,573
20 Day Average Volume649,536
30 Day Average Volume590,928
50 Day Average Volume730,711
Alpha0.015699
Beta0.1895
Standard Deviation0.256712
R20.001688
7 Day Price Change$ -0.40
7 Day Percent Change-5.27%
21 Day Price Change$ -0.83
21 Day Percent Change-10.35%
30 Day Price Change$ 0.01
30 Day Percent Change0.14%
Month to Date Price Change$ -0.62
Month to Date Percent Change-7.94%
Quarter to Date Price Change$ -1.42
Quarter to Date Percent Change-16.49%
180 Day Price Change$ 2.09
180 Day Percent Change40.98%
200 Day Price Change$ 1.65
200 Day Percent Change29.78%
Year to Date Price Change$ -9.53
Year to Date Percent Change-57.0%

Kezar Life Sciences Inc. (KZR) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.70
Total Debt To Equity0.10
Int Coverage-63.60
Current Ratio31.20
Leverage Ratio1.10
Quick Ratio30.30
Long Term Debt To Capital0.04
VALUATION MEASURES
PE Ratio-6.90
Enterprise Value$ 206,365,877
Price to Sales0.00
Price to Free Cash-8.70
PE High Last 5 Years0.00
Price To Book1.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-29.50
Return on Equity-31.92
Return on Capital-31.01

Kezar Life Sciences Inc. (KZR) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG LLP
CEOJohn Franklin Fowler
Emplyoees56
Last AuditUQ
CIK0001645666
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address4000 Shoreline Court
Suite 300
South San Francisco, CA 94080
Websitehttps://www.kezarlifesciences.com
Facsimile-
Telephone+1 650 822-5600
EmailIR@kezarbio.com
Your Recent History
NASDAQ
KZR
Kezar Life..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221207 18:01:41